FDA approves IPL device to manage dry eye disease
PB-00038930 Rev A
Patented Lumenis Optimal Pulse Technology (OPT) becomes the first IPL approved for management of dry eye disease due to MGD, and Lumenis launches OptiLight.
PB-00038930 Rev A